- Home
- / Vascular Pharmaceuticals
Vascular Pharmaceuticals
Total Funding
$28 M
Vascular Pharmaceuticals Summary
Company Summary
- Overview
- Vascular Pharmaceuticals is a biopharmaceutical company specializing in the complications of diabetes, specifically diabetic nephropathy. The company aims to advance its therapeutic candidate, VPI-2960B, through clinical development. It inhibits the αVß3 receptor on kidney cells to halt and even reverse the effect of kidney disease.
- Type
- Private
- Status
- Active
- Founded
- 2005
- HQ
- NC, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
David Clemmons, Co-Founder, Chief Scientific Officer
Laura Maile, Co-Founder, Director, Research and Development
Elizabeth Stoner, Chief Development Officer
LocationsView all
2 locations detected
NC HQ
United States
79 TW Alexander Dr, Research Triangle
Chapel Hill, NC
United States
510 Meadowmont Village Cir #283
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026